Nombre del producto:6-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one

IUPAC Name:6-bromo-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one

CAS:888721-83-3
Fórmula molecular:C6H4BrN3O
Pureza:95%+
Número de catálogo:CM103536
Peso molecular:214.02

Unidad de embalaje Stock disponible Precio($) Cantidad
CM103536-10g in stock Ǒȯƥ
CM103536-25g in stock ƃȯƛ
CM103536-100g in stock ŵȯǑ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :888721-83-3
Fórmula molecular:C6H4BrN3O
Punto de fusión:-
Código de sonrisas:BrC1=CN2N=CNC(=O)C2=C1
Densidad:
Número de catálogo:CM103536
Peso molecular:214.02
Punto de ebullición:
Nº Mdl:MFCD11973831
Almacenamiento:2-8°C

Category Infos

Pyrroles
Pyrrole is a five membered heterocyclic compound with the molecular formula of C4H5N. Pyrrole has a ring composed of four carbon atoms and one nitrogen atom. Pyrrole is easy to polymerize in the air. Pyrrole is the parent compound of many important biological substances (such as bile pigment, porphyrin and chlorophyll). Pyrrole scaffolds are widely used in biological and pharmaceutical fields. Pyrrole is a special heterocyclic scaffold, which exists in many natural products, drug molecules and pesticides, and has shown its application in materials science.
Pyrrole,Where to Buy Pyrroles-Chemenu
Pyrrole,Where to Buy Pyrroles
Pyrrole is a heterocyclic, aromatic, organic compound, a five-membered ring with the formula C 4H 4NH. It is a colorless volatile liquid that darkens readily upon exposure to air. Substituted derivatives are also called pyrroles, e.g., N-methylpyrrole.

Column Infos

Avapritinib
Blueprint Medicines announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe.  AYVAKYT was designed to potently and selectively target KIT D816V, the primary underlying driver of the disease.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products